Assessment of Vascular Endothelial Growth Factor in Fresh versus Frozen Platelet Rich Plasma.

Nada Hosny, Fikry Goubran, Basma BadrEldin Hasan, Noha Kamel
Author Information
  1. Nada Hosny: Clinical Pathology Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
  2. Fikry Goubran: Clinical Pathology Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
  3. Basma BadrEldin Hasan: Clinical Pathology Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
  4. Noha Kamel: Clinical Pathology Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.

Abstract

Platelet rich plasma (PRP) is hemoconcentration with platelets concentration above baseline values and high concentration of many growth factors. The aim of this study was to assess freezing effect on vascular endothelial growth factor (VEGF) release from PRP using two different activation methods to simplify its use in different clinical applications. PRP was prepared using two-centrifugation steps method from 12 qualified blood donors. VEGF concentrations were measured in fresh PRP and after freezing/thawing for one and three weeks with two methods of activation using (i) calcium gluconate and (ii) calcium gluconate and thrombin. Platelets count was significantly increased compared to baseline whole blood values in all fresh and frozen PRP samples (p value was <0.05). No significant difference was found between VEGF concentrations after activating fresh and frozen-thawed PRP samples for one and three weeks by calcium alone or calcium with thrombin, and also no significant difference was found when freezing period was extended from one to three weeks. Our results showed that platelets count does not correlate with variable levels of VEGF. PRP could be prepared once and preserved frozen for at least three weeks for the next treatment sessions and activation with thrombin addition to calcium will not augment the growth factor release.

References

  1. Biomed Res Int. 2014;2014:692913 [PMID: 25136613]
  2. Int J Oral Maxillofac Implants. 2002 Mar-Apr;17(2):184-90 [PMID: 11958400]
  3. Clin Oral Implants Res. 2003 Jun;14(3):357-62 [PMID: 12755786]
  4. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jun;85(6):638-46 [PMID: 9638695]
  5. Eur Cell Mater. 2010 Jul 26;20:84-97 [PMID: 20661865]
  6. J Bone Joint Surg Am. 2012 Feb 15;94(4):308-16 [PMID: 22336969]
  7. Open Orthop J. 2013 May 03;7:120-8 [PMID: 23730375]
  8. Stem Cell Res Ther. 2013 Jun 07;4(3):67 [PMID: 23759113]
  9. Blood Transfus. 2013 Oct;11(4):611-22 [PMID: 24120611]
  10. Biores Open Access. 2012 Jun;1(3):115-23 [PMID: 23516671]

Word Cloud

Created with Highcharts 10.0.0PRPcalciumVEGFthreeweeksgrowthusingactivationfreshonethrombinPlateletplateletsconcentrationbaselinevaluesfreezingfactorreleasetwodifferentmethodspreparedbloodconcentrationsgluconatecountfrozensamplessignificantdifferencefoundrichplasmahemoconcentrationhighmanyfactorsaimstudyassesseffectvascularendothelialsimplifyuseclinicalapplicationstwo-centrifugationstepsmethod12qualifieddonorsmeasuredfreezing/thawingiiPlateletssignificantlyincreasedcomparedwholepvalue<005activatingfrozen-thawedalonealsoperiodextendedresultsshowedcorrelatevariablelevelspreservedleastnexttreatmentsessionsadditionwillaugmentAssessmentVascularEndothelialGrowthFactorFreshversusFrozenRichPlasma

Similar Articles

Cited By